Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Precision Health Database|Search|PHGKB

Last data update: Sep 22, 2023. (Total: 61629 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 402 Records)

Next

Query Trace:
Targeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myeloma
SM Setayesh et al, NPJ Prec Oncol September 18, 2023
Assessing the Clinical Utility of Liquid Biopsies Across 5 Potential Indications From Therapy Selection to Population Screening: A Review.
David J Carr et al. JAMA Intern Med 2023
Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial.
Miguel García-Pardo et al. JAMA Netw Open 2023 6(7) e2325332
Genome-wide mutation profiles from cell-free DNA for early cancer detection
Nature Genetics, July 31, 2023
Practical recommendations for using ctDNA in clinical decision making.
Stacey A Cohen et al. Nature 2023 619(7969) 259-268
Mutations in epigenetic regulator KMT2C detected by liquid biopsy are associated with worse survival in prostate cancer patients.
Sha Zhu et al. Oncol Res 2023 31(4) 605-614
Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer.
Rocco M Ferrandino et al. JAMA Otolaryngol Head Neck Surg 2023
Fragmentomics - the future of cfDNA testing?
H Wilson, PHG Foundation, July 4, 2023
Study of Liquid-Based Cytology Using Next-Generation Sequencing as a Liquid Biopsy Application in Patients with Advanced Oncological Disease.
Karla Beatríz Peña et al. Biomedicines 2023 11(6)
Private Payer and Medicare Coverage Policies for Use of Circulating Tumor DNA Tests in Cancer Diagnostics and Treatment.
Michael P Douglas et al. J Natl Compr Canc Netw 2023 21(6) 609-616.e4
Circulating tumour cells for early detection of clinically relevant cancer.
Rachel Lawrence et al. Nat Rev Clin Oncol 2023 1-14
Clinical Outcomes Beyond 1L EGFR-TKI Progression in mNSCLC: Final Results of the Real-World Study 'LUNGFUL'.
Giannis Mountzios et al. Anticancer Res 2023 43(5) 2243-2258
Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer.
Chiara Nicolazzo et al. Front Oncol 2023 131160673
Potential utility of risk stratification for multicancer screening with liquid biopsy tests
ES Kim et al, NPJ Precision Oncology, April 22, 2023
Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation.
Shaobo Mo et al. JAMA Oncol
Liquid Biopsy Assessment of Molecular Residual Disease in Localized Colorectal Cancer: Is It Ready for Prime Time?
Juan Ruiz-Bañobre et al. JAMA Oncol
Utilization of Circulating Tumor Cells in the Management of Solid Tumors
PC Kumiali et al, J Per Med, April 20., 2023
Liquid Biopsy in Endometriosis: A Systematic Review.
Carlo Ronsini et al. Int J Mol Sci 2023 24(7)
High-resolution circulating tumor DNA testing predicts survival in metastatic lung cancer clinical trials.
et al. Nat Med 2023
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA.
Christopher Abbosh et al. Nature 2023
Top advances of the year: Precision oncology.
Aakash Desai et al. Cancer 2023
Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital.
Sandra Pinet et al. Frontiers in oncology 2023 131104659
Significance of Distinct Liquid Biopsy Compartments in Evaluating Somatic Mutations for Targeted Therapy Selection in Cancer of Unknown Primary.
Fiona R Kolbinger et al. Journal of gastrointestinal cancer 2023
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer.
Aleix Prat et al. Nature communications 2023 14(1) 1157
Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility.
Anthony Pak-Yin Liu et al. Laboratory investigation; a journal of technical methods and pathology 2023 102(2) 134-142
Combined low-pass whole genome and targeted sequencing in liquid biopsies for pediatric solid tumors
E Chistodoulou et al, NPJ Precision Oncology, February 20, 2023
Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors.
Fatemeh Ardeshir-Larijani et al. JCO precision oncology 2023 7e2200465
Liquid Biopsy for Guiding Treatment Decisions in Advanced Non-Small Cell Lung Cancer.
Gretchen Suk et al. Journal of the advanced practitioner in oncology 2023 13(8) 790-795
Liquid Biopsy for Oral Cancer Diagnosis: Recent Advances and Challenges
Y Naito et al, J Per Med, February 8, 2023
Molecular Basis of HER2-Targeted Therapy for HER2-Positive Colorectal Cancer.
Yoshikawa Ayumu et al. Cancers 2023 15(1)
TOP